A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. (Q33337500)

25 July 2017

title

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

Yamada Y

1 reference

25 July 2017

Tomonaga M

1 reference

25 July 2017

Fukuda H

1 reference

25 July 2017

Hanada S

1 reference

25 July 2017

Utsunomiya A

1 reference

25 July 2017

Tara M

1 reference

25 July 2017

Sano M

1 reference

25 July 2017

Ikeda S

1 reference

25 July 2017

Takatsuki K

1 reference

25 July 2017

Kozuru M

1 reference

25 July 2017

Araki K

1 reference

25 July 2017

Kawano F

1 reference

25 July 2017

Niimi M

1 reference

25 July 2017

Tobinai K

1 reference

25 July 2017

Hotta T

1 reference

25 July 2017

Shimoyama M

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

British Journal of Haematology

25 July 2017

published in

1 reference

25 July 2017

volume

113

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

375-382

1 reference

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

The third nation-wide study on adult T-cell leukemia/lymphoma (ATL) in Japan: Characteristic patterns of hla antigen and HTLV-I infection in atl patients and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02737.X

10.1046/J.1365-2141.2001.02737.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference